Xontogeny LLC 13D/13G Filings for

Xontogeny LLC 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-06-25
5:01 pm
Purchase
2021-06-08 13D Astria Therapeutics, Inc.
ATXS
Xontogeny LLC 1,281,198
9.900%
1,281,198increase
(New Position)
Filing